Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bruton Tyrosine Kinase Inhibitor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04624906
What this trial is testing

Bendamustine, Rituximab and Acalabrutinib in Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom Macroglobulinemia
Sunnybrook Health Sciences Centre 63
Large-scale testing (Phase 3)Active Not RecruitingNCT04662255
What this trial is testing

Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL)

Who this might be right for
Lymphoma, Mantle-Cell
Loxo Oncology, Inc. 500
Early research (Phase 1)Study completedNCT05190068
What this trial is testing

HMPL-760 in Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
B-Cell Non-Hodgkin's Lymphoma
Hutchmed 89
Large-scale testing (Phase 3)Study completedNCT02947347
What this trial is testing

Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Pharmacyclics LLC. 445
Testing effectiveness (Phase 2)Study completedNCT01325701
What this trial is testing

Safety and Efficacy Study of a BTK Inhibitor in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large Cell B-lymphoma
Pharmacyclics LLC. 78
Not applicableLooking for participantsNCT07099443
What this trial is testing

Determinants of the Response to BTK Degraders (BTKd) in Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic LeukemiaBTK Degraders
Nantes University Hospital 60
Testing effectiveness (Phase 2)Study completedNCT05068440
What this trial is testing

Treatment of CD79B Mutant Relapsed/Refractory Diffuse Large B-Cell Lymphoma With Bruton Tyrosine Kinase Inhibitor Zanubrutinib

Who this might be right for
Relapsed Diffuse Large B-cell LymphomaRefractory Diffuse Large B-cell Lymphoma
BeiGene 65
Testing effectiveness (Phase 2)Active Not RecruitingNCT04234061
What this trial is testing

Clinical Trial to Assess The Efficacy and Safety of the Combination of Tisagenlecleucel And Ibrutinib in Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma Recurrent
Peter MacCallum Cancer Centre, Australia 20
Early research (Phase 1)Active Not RecruitingNCT01479842
What this trial is testing

Rituxan/Bendamustine/PCI-32765 in Relapsed DLBCL, MCL, or Indolent Non-Hodgkin's Lymphoma

Who this might be right for
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Adult Diffuse Large Cell Lymphoma+7 more
Kami Maddocks, MD 48
Early research (Phase 1)Study completedNCT04436107
What this trial is testing

Zanubrutinib, in Combination With Lenalidomide, With or Without Rituximab in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
BeiGene 66
Testing effectiveness (Phase 2)Active Not RecruitingNCT02180711
What this trial is testing

Study of Acalabrutinib Alone or in Combination Therapy in Subjects With B-cell Non-Hodgkin Lymphoma

Who this might be right for
Non Hodgkin Lymphoma
Acerta Pharma BV 113
Early research (Phase 1)Study completedNCT02303392
What this trial is testing

Selinexor and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Aggressive Non-Hodgkin Lymphoma

Who this might be right for
Prolymphocytic LeukemiaRecurrent Adult Diffuse Large Cell LymphomaRecurrent Mantle Cell Lymphoma+2 more
Jennifer Woyach 34
Early research (Phase 1)Study completedNCT02556892
What this trial is testing

Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Treatment-naive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Who this might be right for
Lymphocytic Leukemia
Janssen Pharmaceutical K.K. 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT04947319
What this trial is testing

Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study)

Who this might be right for
Refractory Primary Central Nervous System LymphomaPrimary CNS Lymphoma
Ono Pharmaceutical Co., Ltd. 119
Not applicableUnknownNCT06130709
What this trial is testing

IRAF-ABLATION Study: a Multicenter International Retrospective Cohort of Patients With BTK Inhibitors-related AF Treated by Catheter Ablation

Who this might be right for
BTKi-induced Atrial FibrillationHematologic MalignancyAtrial Fibrillation Catheter Ablation
University Hospital, Caen 100